Intervention

VRC-HIVMAB060-00-AB (VRC01)

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown1

Clinical trials

3 shown

Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment InterruptionsNCT03831945 · 2019-04-04

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy AdultsNCT02599896 · 2015-11-16

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment InterruptionNCT02471326 · 2015-07-13

Common conditions

HIV2 HIV Antibodies1 Monoclonal Antibody, Human1 Neutralizing Antibody1 Prevention of HIV Infection1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)3

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.